Australian Natural Therapeutics Group (ANTG) is a leader in the production of premium-grade Australian-made medicinal cannabis, defined by its world-class standards and commitment to research and evidence.
We are a dedicated team of industry experts, scientists, and individuals deeply committed to prioritising people’s well-being United in being a global leader in making a meaningful difference to people’s lives through our passion for natural medicine.
From seed to shelf, our priority is delivering consistent, high-quality results that meet the highest standards. Our patients come first— we listen and act with pure intent, always considering their needs. We strive to establish meaningful connections and foster long-term relationships built on trust and reliability.
We believe the development of optimal genetics is paramount.
Selective breeding has allowed us to create plant varieties rich in medicinal content, unique terpene profiles and yield quality.
Grounded in innovation, we invest hundreds of hours developing cultivar-specific plant-based medicine, unique to us.
ANTG is a leading producer of premium-grade plant-based medicines, using optimal genetics and best-practice cultivation.
In our state-of-the-art facilities across the country, we apply well-established horticultural methodology for consistent yield and quality.
As an Australian GMP-certified company, our entire production and manufacturing processes are independently verified to the highest pharmaceutical quality standards worldwide.
Our rigorous approach to quality assurance ensures our industry-leading products are highly controlled, and standardisation on processes and testing are both predictable and reproducible, two fundamental indicators of pharmaceutical quality.
ANTG’s R&D activities has two distinct functions: product development and clinical research.
With a focus on delivering multiple whole plant formats of the same cultivar, our R&D department is constantly innovating to ensure we develop a variety of products to suit the individual needs of our patients.
We see the advancement of scientific knowledge as the main driver of progress and change within the medicinal plant-based industry and wider community. As such, investing in clinical research is a fundamental part of our business model. The R&D department manages several research projects with our university partners from pre-clinical laboratory studies to large-scale human clinical trials. These are documented on our research page.
Founded on compassion, ANTG’s commitment to higher standards is not just a philosophy; it is a way of life. It is a steadfast commitment to excellence, compassion, and innovation that guides us in everything we do, ensuring that we continue to make a meaningful and lasting impact in the communities we serve. In our ongoing mission to serve the community, we actively engage in initiatives that promote health, wellness, and social responsibility. Whether it’s supporting local charities, sponsoring educational programs, or participating in community events, we are dedicated to making a meaningful impact in the communities we serve.
Australian Natural Therapeutics Group (ANTG) was founded on the principles of care, quality, and compassion.
In this developing industry, the collection of scientific knowledge in the form of evidence, research and data is essential.
Our focus on Research and Development aims to better understand the potential therapeutic value of plant-based medicine, and its interaction with biological systems.
Our mission is to enhance the well-being of our community.
Australian Natural Therapeutics Group was founded in 2016 by entrepreneur Matthew Cantelo, who witnessed the popularisation of cannabis for medicinal use while he was based in Denver, Colorado.
Matt observed how this emerging field of healthcare was changing lives and health outcomes, and it was there that he formed a clear vision to build a company that would produce premium-grade medicinal cannabis, backed by research and evidence.
In those early days, Matt was also dealing with the heavy burden of seeking help for his father, watching him struggle in the final stages of prostate cancer, and battling through pain management treatments with limited success.
He envisioned being able to help patients like his dad by forming an Australian-owned company.
Sadly, Matt’s father Ross, affectionately known as ‘Rocky’ passed away as Matt was still building his dream, founding ANTG from the ground up.
However, Rocky’s’ legacy has proved a powerful one, living on through the high-THC flower bred and cultivated in his name, a cultivar that helps bring pain relief to thousands of Australians every day.
In this developing industry, the collection of scientific knowledge in the form of evidence, research and data is essential.
Producing high quality plant-based medicine relies on agronomic efficiency and advanced production methods.
At ANTG, our operations include:
Product development
The research and development function is at the forefront of product development and delivery technologies to ensure our products achieve the best patient outcomes.
Plant breeding and genetics
ANTG has a dedicated plant performance team to internally breed and develop new plant genetics to underpin our scientific research on patient care. Several years of cultivation research and development trials have gone toward identifying ideal environmental and nutritional requirements of our plants.
Certified GACP Standard
Our propagation and cultivation practices are independently certified to surpass Good Agricultural and Collection Practices standards ensuring the quality and purity of our agronomic processes and outputs.
Manufacturing and extraction
As an Australian GMP-certified company, our production and manufacturing processes are independently verified to the highest pharmaceutical quality standards worldwide.
Quality Assurance
Our rigorous approach to quality assurance ensures our products are highly controlled, and standardisation on processes and testing are both predictable and reproducible, two fundamental indicators of pharmaceutical quality.
Our focus on Research and Development aims to better understand the possible therapeutic value of plant-based medicine, and its interaction with biological systems.
We partner with leading scientists and Universities to develop clinically relevant evidence for the safe and effective use of cannabinoid therapy for Australian patients.
Investment in research is one of our proudest achievements.
In 2017 ANTG partnered with biomedical scientist and cancer researcher Associate Professor Matt Dun, examining the first of of our proprietary cultivars – and CBD dominant chemovar.
The team of scientists from Hunter Medical Research Institute (HMRI) at the University of Newcastle was seeking to expand their understanding of plant-based medicine in the prevention and treatment of diseases.
After almost two years of focused research examining the anti-cancer properties of our plant extract, they discovered this plant variety could kill cancer cells in vitro.
And the research continues to evolve.
New research from the HMRI team is investigating what makes cancer cells sensitive and normal cells not, whether it is clinically relevant, and whether a variety of cancers respond.
Studies are progressing to test our plant extracts in animal models and if the results are encouraging, studies could progress to human clinical trials.
Our mission is to enhance the well-being of our community. Our social responsibility to healthcare professionals and patients is to provide education and evidence-informed research.
We are passionate about producing the highest quality plant-based medicine. We lead with our values, taking pride and care in all that we do, from best practice cultivation methods to meeting strict quality assurance standards.
We care about what happens in the community and safeguard patient care by ensuring we meet the highest standards in the practice of plant-based therapies. Each individual should have the opportunity to make an informed decision on what is best for them.
We support compassionate access of medicines for all Australians, leading advocacy efforts to establish a national federal government scheme, backed by industry.
Led by a board of skilled commercial leaders, our multidisciplinary team includes expert horticulturalists, scientific researchers and medical advisors. Motivated by the profound health benefits of plant-based therapies, we are passionate about improving the lives of our patients.
Founder & Chief Executive Officer
Matt leads the ANTG team. A former director and COO of one of the world’s leading travel management companies, Matt co-founded ANTG in 2015. Matt is deeply passionate about the power and potential of plant-based therapies, and the people it can help. Matt is an investor and advisor to many successful ventures across a number of sectors including technology, security, social media, real estate, nutrition and fitness.
“It is incredible to watch how fast this industry is growing. Every year we see advancements in scientific research, an increase in patient numbers and wider community acceptance. ANTG is uniquely positioned to have an enormous impact world-wide. That’s what motivates me every day.”
Chief Operating Officer
James oversees the business operations and corporate development of ANTG. With an executive leadership background in the travel, technology and advertising industries, James has led brands, projects and operational initiatives globally in travel, IT, automotive, CPG, finance, beauty and manufacturing. James also serves as an investor and board advisor to a number of businesses in security technology, travel distribution, talent management and recruitment.
“Every day I am working with, and learning from, an incredible team of people that are patient-centric and committed to quality every step of the way – from plant to finished medicine.”
Chief Financial Officer
As Chief Financial Officer, Max leads ANTG’s finance team, driving financial outcomes, actively managing the group’s financial performance, optimizing the business’s balance sheet and communicating the group’s strategic and financial priorities to stakeholders, including investors. With a background in corporate finance and advisory, Max’s experience includes over 10 years of senior level advisory roles to financiers, investors, boards and management across a diverse range of industries.
Non-Executive Director
Known by his peers and colleagues as a source of wise counsel and as an influential agent for positively positioning business for growth, Bernard Morrow is a respected professional who leads with confidence and approaches the most difficult and complex challenges with perseverance, acumen, commitment and consistency.
As a seasoned, business-centric accountant and adviser, Bernard has almost 40 years experience as a leader in professional services, lastly over the past 20 years as the founder of his own specialist practice after a distinguished career as a Partner at PricewaterhouseCoopers following him “cutting his teeth” in number of formative roles.
His areas of expertise are corporate governance, strategic planning and execution, capital sourcing and allocation, business fiscal management, and international expansion. Despite his tertiary education and professional experience being centred around matters of money, Bernard is passionate about sustainable stakeholder value creation and businesses creating legacies beyond economic outcomes.
He takes a balanced and practical approach, whilst maintaining a sense of perspective and fitness-for-purpose, to guiding organisations as they constantly innovate, managing growth and its challenges, adopting new technologies and methods, dealing with regulatory change, and facing ever-evolving economic and competitive landscapes.
Bernard holds a Bachelor of Business in Accountancy, a Graduate Diploma in Corporate Management and a Master of Business Administration in International Management. He is a Fellow of CPA Australia, a Fellow of the Institute of Public Accountants, and a Member of the Australian Institute of Company Directors.
Bernard lives in Melbourne and shares his time between there and his beloved beach home in South Gippsland.
“It is a privilege to work with a dedicated group of highly motivated people that genuinely seek and demonstrably act to create legacies beyond just purely economic outcomes.”
Non-Executive Director
René van der Merwe is a highly regarded executive and non-executive director with over 25 years of diverse experience spanning chemistry, quality management, project execution, governance, innovation, sustainability, safety, and business continuity. Her career has traversed industries such as logistics, aviation, automotive, and FMCG, providing her with a deep understanding of organizational dynamics, management systems, and enterprise risk management.
René has a proven track record of success at the board level, holding prominent roles such as Chair of the Area Risk and Compliance Committee (ARCC) for Maersk Oceania and serving two terms as a Non-Executive Board Member of the Australian Institute of Health and Safety (AIHS), where she also contributes as a member of the Audit and Risk Committee. Additionally, she played a key role in establishing governance through the Qantas’s Committee for Health, Environment, Safety & Security and the Airline Governance Sub-Committees.
With a Bachelor of Science (Honours) in Chemistry, a Diploma in Project Management, and a Graduate Certificate in Safety Leadership, René combines academic rigor with practical expertise. Her strategic insights and commitment to governance excellence make her a valued contributor to board leadership, driving sustainable outcomes and fostering organizational growth.
“Excited to support the ANTG team to build a sustainable business that will continue to support our patients and the broader community we serve with readily available, high-quality products, leaving a remarkable legacy of trust and care.”
Director of Plant Performance and Genetics
Rangi worked in aquaculture hatcheries for over a decade until 2015 when he followed his calling to help create plant-based medicines in Australia. Rangi obtained a hemp research licence and a cultivation facility and began to selectively breed for specific profiles suitable for therapeutic use.
Rangi is the director of plant genetics, plant performance and crop scheduling across several sites. He has bred and tested several hundreds of plants using high-pressure liquid chromatography (HPLC) and is also trained and experienced in the operation of supercritical Co2, ethanol and distillation extractions and formulations.
“I love the process of developing new and innovative strains of plant-based medicines. It’s an amazing feeling seeing a new product hit the market after years of research and development.”
Executive General Manager of Manufacturing
Andrew has a strong operations background in Lean Six Sigma, strategic planning, facility build outs and business start ups, and is a very capable leader in developing high performing production teams across numerous pharmaceutical manufacturing businesses.
Andrew has extensive knowledge in the manufacturing of API, oral liquids, softgel liquid filled capsules, 2 piece hardshell capsules, solid dose coated tablets, effervescent tablets, and nutritional powders. He also has product introduction experience in the manufacturing of plant medicines, high potency medicines, and a multitude of Nutraceutical products.
Andrew also brings over 15 years leadership experience in food and pharmaceutical industries, with a thorough knowledge of processes and quality requirements to ensure compliance and best practice is achieved whilst meeting strict TGA, ODC and GMP guidelines.
Special Projects
Backed by a wealth of experience in GMP/GACP horticulture and high-tech farming, Jarrad brings a strong background in construction, project management, and strategy & negotiation. Jarrad has developed numerous industry contacts in international markets and has acquired extensive experience in best-practice facility design, large-scale cultivation techniques, standard operating procedures, and controlled environment facilities.
“The cross-over between the agriculture and pharmaceutical industries is such an interesting space that requires a great deal of innovation. Creating high-quality medicine that changes people’s lives is the most rewarding thing.”
Chief Scientific Officer
Researcher and Pharmacognosist Justin Sinclair has been formally studying medicinal plants and fungi since 1998. In 2015 he was made a member of the Scientific Advisory Board of United in Compassion, a medicinal cannabis patient support and advocacy group that was fundamental in changing regulations around medicinal cannabis in Australia. Justin was also appointed as a board member of the Australian Medicinal Cannabis Association in August 2020.
Justin advises the Psychae Institute and Society of Cannabis Clinicians (Australian Chapter) on technical and scientific matters. Justin has been heavily involved in various medicinal cannabis education programs since 2016, providing over 140 lectures to industry leaders, healthcare professionals and patients. Justin is currently completing his doctoral studies at NICM Health Research Institute (Western Sydney University) investigating the safety, tolerability, and effectiveness of medicinal cannabis for endometriosis, and has published 3 book chapters and 22 peer-reviewed journal articles on medicinal cannabis since 2016. In his free time, Justin enjoys wandering through old-growth forests, learning about medicinal plants from First Nations peoples and perhaps not surprisingly… gardening.
“I am very passionate about helping patients. Researching and producing plant-based medicines that can improve patient outcomes when standard medical treatments fail is my foremost motivation.”
Head of Sales
Steve Bowne is an experienced industry leader with a passion for creating winning outcomes through collaborative leadership, creative strategy development, driving change and accountable execution.
Skilled in building work environments that attract engaged, valued, and motivated sales professionals, Steve highly values the concept of creating and performing meaningful work.
Steve joined ANTG in July 2023 as the new Head of Sales, bringing two decades of big pharma and healthcare industry experience and an inclusive approach that prizes great culture and ethical leadership.
“Being part of an organisation that works for the best interests of Australian patients is important to me. Seeing the positive difference medicinal cannabis does make to people’s lives serves to amplify the meaning in what we are doing at ANTG….It’s why I get out of bed.”
Head of Communications & Community
One of Australia’s most respected broadcasters, Helen Kapalos is a seasoned communications practitioner with more than twenty years of experience in the Australian Television industry.
Helen is also an award-winning independent filmmaker. Her 2015 breakthrough feature film, ‘A Life of its Own,’ detailing the medicinal cannabis debate in Australia, was distributed globally by Netflix, broadcast on SBS TV and Foxtel’s streaming service Binge.
In 2015 Helen was appointed to serve a four-year term as the Victorian state-appointed Commissioner for Multiculturalism and in recognition of her services, awarded the inaugural Vice-Chancellors Fellow for Multicultural Engagement at Swinburne University.
Helen continues to take a leading role in advocating for more education and awareness around the therapeutic use of plant-based therapies in the community.
“I have dedicated my life to this story. How could I not after seeing the high-value health outcomes in the community. Now, for more education and awareness!”
Marketing Manager
With over 15 years of experience, Angelique has held senior marketing roles at prominent companies such as News Ltd, Vodafone, Village Roadshow, and Brisbane Festival. Her career includes leading the international expansion of Australian skincare brand, MooGoo. Driven by a passion for plant-based ingredients and sustainability, Angelique also founded NEEK Skin Organics, an all-natural, vegan cosmetics line. Under her leadership, NEEK Skin Organics grew to 15 products, available in 200 stores worldwide, including Urban Outfitters in the US and Ocado in the UK.
“With a strong commitment to plant-based sustainability and years of marketing experience, I use my background with global brands to explore new opportunities in the medicinal cannabis sector, focusing on natural wellness and ethical practices.”
General Manager, Products and Portfolio
Matt holds a science degree in sustainable resource management and marine biology. Working across the medicinal plant industry, Matt has gained a diverse range of experience in plant breeding, propagation, cultivation, and post-harvest activities.
As GM of Products and Portfolio, Matt leads the GMP team in the post-harvest operations of the business, ensuring visibility and compliance at all points in the material movement chain. He has oversight of all shipping movements globally and oversees a high-level internal and external product review and sensory panel.
“Working within a team of incredibly talented individuals united by our passion for the plant and the people it serves is what motivates me to do my job to the highest standard.”
Medical Science Liaison
Daniel thrives on building genuine relationships with healthcare practitioners rooted in trust and effective education. His attention to detail and extensive knowledge of plant-based medicines ensure a valuable partnership aimed at optimising patient outcomes.
Daniel’s 17+ years of work experience in the healthcare industry encompasses an array of skills: pharmacy territory management; nutrition clinical practice; technical article writing; probiotic and nutraceutical product development/stability; and gut microbiome metagenomic test training for practitioners. Daniel is very excited about the opportunity to advocate and educate on the positive patient outcomes that ANTG’s plant-based medicines can bring to the community.
Medical Science Liaison
Diane has worked in the Pharma industry since 2015 and in the medicinal cannabis industry for the past two years, which includes experience in the international sector. Prior to that, Diane worked in several roles as a Business Development Manager, instructor, and trainer. She is passionate about educating healthcare professionals and empowering the practitioner and patient through knowledge about the cannabis plant, as well as the latest research and developments. She is motivated by improving the clinical and patient experience at all levels, and playing an important role in helping to bridge the gap for practitioners at the start of their journey.
Medical Science Liaison
Andrew Whitfield-Cook has over thirty years of experience in the natural medicine industry and professions, having worked in sales, product development and manufacturing, research liaison, training and education, and media production.
Andrew is a renowned interviewer and podcast host across the Natural/Functional Medicine professions. Previously of Fx Medicine Podcast, in 2020 Andrew founded Natural Medicine Partners and Natural Medicine Podcast, collaborative educational forums designed to enhance functional medicine practitioners’ knowledge, skillset and safety worldwide. As a Registered Nurse, Andrew is a fierce patient advocate and a resolute supporter of medically prescribed cannabis.
“I’ve been a long-time advocate of patient access to medicinal cannabis ever since I met Justin Sinclair. My drive is to enable patients to access high quality Australian made and responsibly-formulated products.”
Medical Science Liaison
With qualifications in pharmacy, natural medicine and public health, Marleen’s experience spans the pharmaceutical and complementary healthcare industries as a clinical educator, medical marketer and territory manager.
Together with a passion for healthcare professional education, and equitable access to quality healthcare for all patients, Marleen brings her broad experience to ANTG and the medicinal cannabis industry.
“I am excited to be helping healthcare professionals translate emerging medicinal cannabis research into their clinical practice to bring about meaningful change in their patients’ lives”
Export Licence
GMP Licence
Hemp DPI Licence
Import Licence
ODC Permit For Cultivation, Production And Manufacturing
ODC Licence
TGA Medicinal Cannabis Manufacturing Permit
NSW Health S4 Wholesale Licence – Distribution
NSW Health S8 Wholesale Licence – Distribution
NSW Health S8 Wholesale Licence – Manufacture
QLD Health Wholesale Indent Licence
Premier’s NSW Export Awards Regional Exporter Finalist
Cannabiz Award – Product Launch of the Year 2023 – Winner
Cannabiz Award – Cultivator of the Year 2024 – Highly Commended
Cannabiz Award – R&D Project of the Year 2024 – Highly Commended